The use of chlorpromazine for symptom control in dying cancer patients

Journal of Pain and Symptom Management

Volumn 9, Issue 5, 1994, Pages 341-345

  McIver, Beth ^a   Walsh, Declan ^a   Nelson, Kristine ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

delirium; dying; dyspnea; Terminal restlessness

Indexed keywords

CHLORPROMAZINE; MORPHINE;

ADOLESCENT; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER PAIN; CANCER PALLIATIVE THERAPY; CLINICAL ARTICLE; DOSE RESPONSE; DRUG EFFICACY; DRUG MIXTURE; DRUG SAFETY; DYSPNEA; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; RECTAL DRUG ADMINISTRATION; RESTLESSNESS; TERMINAL DISEASE;

CHLORPROMAZINE; HUMAN; NEOPLASMS; TERMINAL CARE;

EID: 0028128309     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/0885-3924(94)90193-7     Document Type: Article

References (15)

1. Terminal restlessness: its management and the role of midazolam
2. Overdosage of psychotropic drugs: a review
3. Analgesia in terminal malignant disease
4. Control of dyspnea in advanced cancer patients
5. Chlorpromazine: a specific effect on breathlessness?
6. Clinical pharmacokinetics of morphine
7. Symptom prevalence and control during cancer patients' last days of life
8. Subcutaneous midazolam infusion in palliative care
9. Barbiturates in the Care of the Terminally Ill
10. Barbiturates in the Care of the Terminally Ill